101 related articles for article (PubMed ID: 9274443)
21. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of anaplasia and angiogenesis in childhood medulloblastoma: a pediatric oncology group study.
Ozer E; Sarialioglu F; Cetingoz R; Yüceer N; Cakmakci H; Ozkal S; Olgun N; Uysal K; Corapcioglu F; Canda S
Pathol Res Pract; 2004; 200(7-8):501-9. PubMed ID: 15462497
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of glial fibrillary acidic protein staining in medulloblastoma.
Goldberg-Stern H; Gadoth N; Stern S; Cohen IJ; Zaizov R; Sandbank U
Cancer; 1991 Aug; 68(3):568-73. PubMed ID: 2065277
[TBL] [Abstract][Full Text] [Related]
24. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
25. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.
Fosså SD; Berner AA; Jacobsen AB; Waehre H; Kvarstein B; Urnes T; Ogreid P; Johansen TE; Silde J; Nesland JM
Br J Cancer; 1993 Sep; 68(3):572-8. PubMed ID: 8102536
[TBL] [Abstract][Full Text] [Related]
27. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
von Hoff K; Hartmann W; von Bueren AO; Gerber NU; Grotzer MA; Pietsch T; Rutkowski S
Pediatr Blood Cancer; 2010 Mar; 54(3):369-76. PubMed ID: 19908297
[TBL] [Abstract][Full Text] [Related]
28. Clinical and molecular stratification of disease risk in medulloblastoma.
Gilbertson R; Wickramasinghe C; Hernan R; Balaji V; Hunt D; Jones-Wallace D; Crolla J; Perry R; Lunec J; Pearson A; Ellison D
Br J Cancer; 2001 Sep; 85(5):705-12. PubMed ID: 11531256
[TBL] [Abstract][Full Text] [Related]
29. Prognostic importance of DNA ploidy in medulloblastoma of childhood.
Yasue M; Tomita T; Engelhard H; Gonzalez-Crussi F; McLone DG; Bauer KD
J Neurosurg; 1989 Mar; 70(3):385-91. PubMed ID: 2915244
[TBL] [Abstract][Full Text] [Related]
30. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
[TBL] [Abstract][Full Text] [Related]
31. Adult medulloblastoma: prognostic factors and patterns of relapse.
Chan AW; Tarbell NJ; Black PM; Louis DN; Frosch MP; Ancukiewicz M; Chapman P; Loeffler JS
Neurosurgery; 2000 Sep; 47(3):623-31; discussion 631-2. PubMed ID: 10981749
[TBL] [Abstract][Full Text] [Related]
32. [Desmoplastic medulloblastoma: histologic factors of prognosis].
Stávale JN; Cruz JR
Arq Neuropsiquiatr; 1993 Dec; 51(4):487-90. PubMed ID: 8147749
[TBL] [Abstract][Full Text] [Related]
33. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
35. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
36. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.
Akslen LA; Varhaug JE
Cancer; 1995 Nov; 76(9):1643-54. PubMed ID: 8635070
[TBL] [Abstract][Full Text] [Related]
37. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Sullivan S; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):18-24. PubMed ID: 9454654
[TBL] [Abstract][Full Text] [Related]
38. MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma.
Wang C; Yun Z; Zhao T; Liu X; Ma X
Cell Physiol Biochem; 2015; 36(4):1430-9. PubMed ID: 26160036
[TBL] [Abstract][Full Text] [Related]
39. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
[TBL] [Abstract][Full Text] [Related]
40. Medulloblastoma: time-dose relationship based on a 30-year review.
del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
